Cargando…
Saccharomyces cerevisiae–based probiotic as novel anti-microbial agent for therapy of bacterial vaginosis
In this study, we demonstrate, for the first time, that Saccharomyces cerevisiae-based probiotic shows an inhibitory effect on Gardnerella vaginalis infection. This effect is likely due to several actions: direct interference with adherence to vaginal tissues, inhibition of sialidase activity, reduc...
Autores principales: | Sabbatini, Samuele, Monari, Claudia, Ballet, Nathalie, Mosci, Paolo, Decherf, Amélie Cayzeele, Pélerin, Fanny, Perito, Stefano, Scarpelli, Paolo, Vecchiarelli, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037478/ https://www.ncbi.nlm.nih.gov/pubmed/29683763 http://dx.doi.org/10.1080/21505594.2018.1464362 |
Ejemplares similares
-
Saccharomyces cerevisiae CNCM I-3856 as a New Therapeutic Agent Against Oropharyngeal Candidiasis
por: Roselletti, Elena, et al.
Publicado: (2019) -
Therapeutic activity of a Saccharomyces cerevisiae-based probiotic and inactivated whole yeast on vaginal candidiasis
por: Pericolini, Eva, et al.
Publicado: (2016) -
Anti-Biofilm Properties of Saccharomyces cerevisiae CNCM I-3856 and Lacticaseibacillus rhamnosus ATCC 53103 Probiotics against G. vaginalis
por: Sabbatini, Samuele, et al.
Publicado: (2020) -
Saccharomyces cerevisiae-Based Probiotics as Novel Antimicrobial Agents to Prevent and Treat Vaginal Infections
por: Gaziano, Roberta, et al.
Publicado: (2020) -
Randomized double blind placebo-controlled trial of Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: improvement in abdominal pain and bloating in those with predominant constipation
por: Spiller, Robin, et al.
Publicado: (2015)